Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2074)	1/16/2008 11:20:04 AM
From: Jibacoa	Read Replies (1) of 3722

CRXL is down >12% after questions about one of its patents for protein production. The stock has now more than closed its Jan 3 UG.<g> bigcharts.marketwatch.com CRXL today reacted to a press release issued by CEVEC Pharmaceuticals GmbH yesterday, in which it announced that one of CRXL's patents for protein production was restricted by a decision of the European Patent Office.(CRXL stated that the suggestions made by CEVEC are misleading.) CRXL stated that the only limitation that was made has no consequence for the scope of protection of the patent as a whole, & the essential claims of the patent for the method of producing a recombinant protein, have been maintained without any limitation. Will see if CRXL can find support at the $15 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next